Austin TX 2型糖尿病临床试验
12项针对 2型糖尿病的研究正在 Austin及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
招募中3 期
- Pinnacle Clinical Research - Austin, Austin
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
招募中3 期
- Texas Diabetes and Endocrinology - Central Austin, Austin
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
招募中3 期
- Texas Diabetes & Endocrinology, Austin
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
招募中3 期
- IMA Clinical Research Austin, Austin
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Austin
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
招募中2 期
- IMA Clinical Research, Austin
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
招募中2 期
- Velocity Clinical Research, Austin, Austin
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
招募中3 期
- Elligo Clinical Research Center, Austin
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
招募中3 期
- Pinnacle Clinical Research, Austin
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
招募中
- Texas Diabetes & Endocrinology, Austin
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
招募中
- Texas Diabetes and Endocrinology, Austin
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
招募中2 期
- Elligo Health Research, Inc., Austin
其他城市的 2型糖尿病试验
- San Antonio, TX37 项研究
- Houston, TX31 项研究
- Orlando, FL24 项研究
- Boston, MA20 项研究
- Chicago, IL19 项研究
- Miami, FL19 项研究
- Dallas, TX19 项研究
- Columbus, OH18 项研究
- Las Vegas, NV18 项研究
- Atlanta, GA17 项研究
- San Diego, CA17 项研究
- Los Angeles, CA16 项研究
Austin的其他研究
- 非小细胞肺癌30 项研究
- 癌症（所有类型）21 项研究
- 肥胖症20 项研究
- 结直肠癌19 项研究
- 转移性癌症19 项研究
- 心力衰竭18 项研究
- 超重18 项研究
- 乳腺癌18 项研究
- 卵巢癌17 项研究
- 子宫内膜癌16 项研究
- 前列腺癌15 项研究
- 抑郁症14 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。